Fresenius Se & Co Kgaa Sponsored American Depository Receipt News, Fresenius Se & Co Kgaa Sponsored American Depository Receipt Quote, FSNUY Quote

Fresenius Se & Co Kgaa Sponsored American Depository Receipt (OP:FSNUY) Delayed: 13.28 +0.12 (0.91%)

Prev. Close

$13.16

Today 6M 1Y 5Y

Open

$13.16

52 Wk High

$20.44

52 Wk Low

$14.74

Day High

$13.40

Day Low

$13.10

P/E

N/A

EPS

$0.00

Volume

61,523

Friends, Peers and Foes (?): FRE:GR FRE (more...)

ALERTS | RSS

Sep 18, 2026 06:16 AM mAbxience and Sandoz Sign a Collaboration Agreement to Advance Biosimilar Access Worldwide
Aug 12, 2026 06:17 AM Fresenius (FRE:GR) (FSNUY) PT Raised to EUR56 at UBS
Aug 10, 2026 04:52 AM Fresenius (FRE:GR) (FSNUY) PT Raised to EUR52 at Morgan Stanley
Aug 6, 2026 07:57 AM Fresenius (FRE:GR) (FSNUY) PT Raised to EUR56 at Deutsche Bank
Aug 6, 2026 04:55 AM Fresenius (FRE:GR) (FSNUY) PT Raised to EUR57.50 at Barclays
Aug 6, 2026 04:38 AM Fresenius (FRE:GR) (FSNUY) PT Lowered to EUR55.20 at JPMorgan
Aug 3, 2026 04:09 PM FDA approves rituximab biosimilar for Fresenius Kabi's U.S. portfolio
Aug 3, 2026 04:09 PM Fresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market
Jul 31, 2026 07:00 AM Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate
Jul 23, 2026 05:16 AM Fresenius establishes venture fund of more than €200 million to drive healthcare innovation

Entities mentioned with FSNUY

View All Entities